跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Ursostar 300
Approved
STANDARD
Ursostar 300
Sapphire Lifesciences Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
01f2b86f21b04cb3
Company
Sapphire Lifesciences Pvt. Ltd
Type
Standard
Approval Details
Approval Id
01f2b86f21b04cb3
Drug Approval Philippines Name
Ursostar 300
Product Name
Ursostar 300
Registration Number
DRP-13681-02
Brand Name
Ursostar 300
Generic Name
Ursodeoxycholic Acid
Dosage Form
Film-Coated Tablet
Dosage Strength
300 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd
Importer
Ollen Pharma Trading Inc
Distributor
Pharmastar Int'l Trading Corp
Issuance Date
28 September 2023
Expiry Date
24 March 2028
Pharmacologic Category
Bile and Liver Therapy (Bile acids and derivative)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
01f2b86f21b04cb3
Type
Standard
Back to Philippines FDA Approvals
Ursostar 300 - Philippines FDA Drug Approval Details